» Articles » PMID: 24642531

Downregulation of ROCK2 Through Nanocomplex Sensitizes the Cytotoxic Effect of Temozolomide in U251 Glioma Cells

Overview
Journal PLoS One
Date 2014 Mar 20
PMID 24642531
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Rho-associated coiled-coil kinase 2 (ROCK2) is an attractive therapeutic target because it is overexpressed in many malignancies, including glioma. Therefore, we designed the current study to determine whether the downregulation of ROCK2 would sensitize the cytotoxic effect of temozolomide (TMZ) in U251 cells.

Methods: Glycol-polyethyleneimine (PEG-PEI) was used to deliver siROCK2 to U251 cells, and the physical characteristics of the PEG-PEI/siROCK2 complex (referred to as the siROCK2 complex) were investigated. The transfection efficiency and cell uptake were determined by flow cytometry (FCM) and confocal laser microscopy (CLSM), respectively. U251 cells were then treated with 100 μM TMZ, siROCK2 complexes or their combination. The apoptosis rate and cell migration were measured by FCM and wound-healing assay, respectively. The levels of Bax, Bcl-2, cleaved caspase-3, MMP-2, and MMP-9 were detected to analyze the degrees of apoptosis and migration.

Results: Our results revealed that the characteristics of the siROCK2 complexes depended closely on the N/P ratios. PEG-PEI served as a good vector for siROCK2 and exhibited low cytotoxicity toward U251 cells. The CLSM assay showed that the siROCK2 complexes were successfully uptaken and that both the protein and mRNA levels of ROCK2 were significantly suppressed. Furthermore, the combination treatment induced a higher apoptosis rate and markedly increased the gap distance of U251 cells in the wound-healing assay. Levels of the proapoptotic proteins Bax and cleaved caspase-3 were significantly increased, whereas levels of the antiapoptotic protein Bcl-2 and the migration-related proteins MMP-2 and MMP-9 were significantly reduced by the combination treatment compared with either treatment alone.

Conclusions: In conclusion, our results demonstrate that the combination of TMZ and siROCK2 effectively induces apoptosis and inhibits the migration of U251 cells. Therefore, the combination of TMZ and siROCK2 complex is a potential therapeutic approach for human glioma.

Citing Articles

LPPR5 Expression in Glioma Affects Growth, Vascular Architecture, and Sunitinib Resistance.

Stange L, Lucia K, Ghori A, Vajkoczy P, Czabanka M, Broggini T Int J Mol Sci. 2022; 23(6).

PMID: 35328529 PMC: 8952597. DOI: 10.3390/ijms23063108.


LncRNA ZFAS1 promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2 pathway by sponging miR-3924.

Liu J, Zhu Y, Ge C Cancer Cell Int. 2020; 20:249.

PMID: 32550827 PMC: 7298847. DOI: 10.1186/s12935-020-01322-8.


RHO GTPases in cancer: known facts, open questions, and therapeutic challenges.

Bustelo X Biochem Soc Trans. 2018; 46(3):741-760.

PMID: 29871878 PMC: 7615761. DOI: 10.1042/BST20170531.


Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells.

Resende F, Titze-de-Almeida S, Titze-de-Almeida R Oncol Lett. 2018; 15(4):4891-4899.

PMID: 29552127 PMC: 5840643. DOI: 10.3892/ol.2018.7917.


Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2.

Zhang X, Liu X, Zhou W, Yang M, Ding Y, Wang Q Cell Death Dis. 2018; 9(2):190.

PMID: 29416017 PMC: 5833824. DOI: 10.1038/s41419-017-0251-9.


References
1.
Das A, Banik N, Patel S, Ray S . Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer. 2004; 3(1):36. PMC: 544397. DOI: 10.1186/1476-4598-3-36. View

2.
Oellers P, Schroer U, Senner V, Paulus W, Thanos S . ROCKs are expressed in brain tumors and are required for glioma-cell migration on myelinated axons. Glia. 2008; 57(5):499-509. DOI: 10.1002/glia.20777. View

3.
Trog D, Yeghiazaryan K, Fountoulakis M, Friedlein A, Moenkemann H, Haertel N . Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells. Eur J Pharmacol. 2006; 542(1-3):8-15. DOI: 10.1016/j.ejphar.2006.05.026. View

4.
Liang Y, Liu Z, Shuai X, Wang W, Liu J, Bi W . Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration. Biochem Biophys Res Commun. 2012; 421(4):690-5. DOI: 10.1016/j.bbrc.2012.03.155. View

5.
Yan B, Chour H, Peh B, Lim C, Salto-Tellez M . RhoA protein expression correlates positively with degree of malignancy in astrocytomas. Neurosci Lett. 2006; 407(2):124-6. DOI: 10.1016/j.neulet.2006.08.032. View